Sexual and Reproductive Health
Testing through GenPath Women’s Health improves the quality of care by using targeted detection in the diagnosis of STIs and other vaginal infections.
GenPath utilizes various multiple nucleic acid amplification tests (NAAT) which are able to identify multiple pathogens from a single collection. Our DNA and RNA amplification techniques provide high sensitivity and specificity compared to other methods.
One Collection, Targeted Detection
GenPath offers healthcare providers the choice of many collection devices in which to collect clinical samples. Thin Prep vial, SurePath vial, Aptima Swab collection, Roche tube, urine cup, Digene Swab and BD ProbeTec Urine Preservation Tube are all available options.
High Sensitivity, High Specificity
GenPath’s molecular testing options definitively identify pathogens to allow for more targeted treatment. The options are especially useful for detecting mixed infections and performance is not affected by collection variables like menses.
Convenience of Testing
The results of GenPath tests come from one laboratory in a concise, easy-to-read report.
Clinically Relevant Profiles
Testing profiles should be ordered based on patient history in conjunction with relevant clinical signs and symptoms.
High Risk STI Profiles
For patients with new or multiple sex partners, in a high-risk demographic (under the age of 25), and/or who are having unprotected sex. Test for chlamydia and gonorrhea with the option of adding trichomonas and/or mycoplasma genitalium.
For patients with visible purulent or mucopurulent exudates from the cervical canal, endocervical bleeding, and/or ulcerative lesions on the ectocervix. Test for chlamydia, gonorrhea, trichomonas, mycoplasma genitalium, and herpes simplex virus types 1 and 2.
PID/Infertility/Pregnancy Loss Profile
For patients with symptoms of pelvic inflammatory diseases (PID) including lower abdominal pain, painful intercourse and urination and/or irregular menstrual bleeding. Patients may also have difficulty getting pregnant or experience multiple pregnancy losses. Tests for infections known to cause PID, including chlamydia, gonorrhea, trichomonas, mycoplasma, bacterial vaginosis organisms, aerobic vaginitis organisms, and ureaplasma.
Bacterial Vaginosis Profile
For symptomatic female patients with dysuria, pruritus, dyspareunia, vaginal discharge, or fishy vaginal odor. Discharge, when present, is usually milky white, but can be yellow or grey. Detects and quantifies lactobacillus species (non-pathogenic), gardnerella vaginalis, and atopobium vaginae. Detects megasphaera type 1 and bacterial vaginosis associated bacterium 2 (BVAB2). BV determination requires testing of all five organisms.
Aerobic Vaginitis (AV) Profile
For symptomatic female patients with dysuria, pruritis, dyspareunia, vaginal discharge, or foul vaginal odor. Detects and quantifies lactobacillus species (non-pathogenic) and detects Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Group A and B Streptococcus. AV determination requires testing of all five organisms.
Vulvovaginal Candidiasis Profile
For symptomatic females with dysuria, pruritus, dyspareunia and curd-like vaginal discharge. Tests for Candida genus and Candida albicans. If Candida genus is positive and Candida albicans is negative, the profile will reflex to five candida species (C. glabrata, C. dubliniensis, C. parapsilosis, C. tropicalis, and C. krusei).
For patients presenting with papules, pustules, vesicles and/or ulcers on mucocutaneous tissue in the genital, anal, or oral areas. Profiles test for a combination of Herpes Simplex Virus (HSV) type 1 and type 2, Varicella Zoster Virus (VZV) Shingles and Treponema pallidum. Testing for LGV and CMV are also available as individual tests.